Jubilant Pharmova Future Growth
Future criteria checks 0/6
Jubilant Pharmova is forecast to grow earnings and revenue by 5.5% and 10.3% per annum respectively. EPS is expected to grow by 10.2% per annum. Return on equity is forecast to be 9.7% in 3 years.
Key information
5.5%
Earnings growth rate
10.2%
EPS growth rate
Pharmaceuticals earnings growth | 17.8% |
Revenue growth rate | 10.3% |
Future return on equity | 9.7% |
Analyst coverage | Low |
Last updated | 26 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 89,202 | 7,793 | 8,104 | 11,957 | 2 |
3/31/2026 | 80,339 | 5,898 | 6,319 | 10,368 | 2 |
3/31/2025 | 72,326 | 7,771 | 5,258 | 14,159 | 1 |
9/30/2024 | 69,197 | 5,931 | -2,744 | 7,676 | N/A |
6/30/2024 | 68,477 | 5,528 | N/A | N/A | N/A |
3/31/2024 | 67,029 | 771 | 736 | 9,713 | N/A |
12/31/2023 | 66,223 | 378 | N/A | N/A | N/A |
9/30/2023 | 64,977 | -446 | 133 | 9,836 | N/A |
6/30/2023 | 64,169 | -1,017 | N/A | N/A | N/A |
3/31/2023 | 62,817 | -610 | -1,538 | 6,607 | N/A |
12/31/2022 | 61,313 | 964 | N/A | N/A | N/A |
9/30/2022 | 58,893 | 1,631 | -1,596 | 4,924 | N/A |
6/30/2022 | 59,472 | 3,004 | N/A | N/A | N/A |
3/31/2022 | 61,302 | 4,139 | 2,376 | 8,375 | N/A |
12/31/2021 | 61,824 | 5,273 | N/A | N/A | N/A |
9/30/2021 | 66,432 | 6,953 | 10,175 | 16,021 | N/A |
6/30/2021 | 65,771 | 6,993 | N/A | N/A | N/A |
3/31/2021 | 60,985 | 5,741 | 12,568 | 17,843 | N/A |
12/31/2020 | 92,659 | 8,339 | N/A | N/A | N/A |
9/30/2020 | 89,744 | 7,759 | 10,031 | 15,596 | N/A |
6/30/2020 | 88,655 | 8,013 | N/A | N/A | N/A |
3/31/2020 | 59,758 | 6,778 | 9,688 | 15,429 | N/A |
12/31/2019 | 91,486 | 5,385 | N/A | N/A | N/A |
9/30/2019 | 92,105 | 5,959 | 7,357 | 13,374 | N/A |
6/30/2019 | 92,140 | 5,569 | N/A | N/A | N/A |
3/31/2019 | 91,108 | 5,745 | 4,656 | 11,215 | N/A |
12/31/2018 | 89,772 | 8,286 | N/A | N/A | N/A |
9/30/2018 | 86,679 | 7,803 | N/A | N/A | N/A |
6/30/2018 | 80,402 | 6,982 | N/A | N/A | N/A |
3/31/2018 | 75,178 | 6,428 | N/A | 13,032 | N/A |
12/31/2017 | 68,641 | 6,381 | N/A | N/A | N/A |
9/30/2017 | 62,545 | 5,449 | N/A | N/A | N/A |
6/30/2017 | 59,982 | 5,613 | N/A | N/A | N/A |
3/31/2017 | 58,614 | 5,757 | N/A | 12,685 | N/A |
12/31/2016 | 58,013 | 4,763 | N/A | N/A | N/A |
9/30/2016 | 57,097 | 4,795 | N/A | N/A | N/A |
6/30/2016 | 57,762 | 4,612 | N/A | N/A | N/A |
3/31/2016 | 57,491 | 3,918 | N/A | 10,989 | N/A |
12/31/2015 | 58,376 | 4,035 | N/A | N/A | N/A |
9/30/2015 | 59,036 | 2,754 | N/A | N/A | N/A |
6/30/2015 | 58,117 | 655 | N/A | N/A | N/A |
3/31/2015 | 58,262 | -578 | N/A | 7,833 | N/A |
12/31/2014 | 58,863 | -17 | N/A | N/A | N/A |
9/30/2014 | 58,837 | 1,529 | N/A | N/A | N/A |
6/30/2014 | 58,641 | 1,664 | N/A | N/A | N/A |
3/31/2014 | 58,034 | 1,090 | N/A | 7,723 | N/A |
12/31/2013 | 55,983 | -207 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 530019's forecast earnings growth (5.5% per year) is below the savings rate (6.7%).
Earnings vs Market: 530019's earnings (5.5% per year) are forecast to grow slower than the Indian market (18.1% per year).
High Growth Earnings: 530019's earnings are forecast to grow, but not significantly.
Revenue vs Market: 530019's revenue (10.3% per year) is forecast to grow slower than the Indian market (10.5% per year).
High Growth Revenue: 530019's revenue (10.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 530019's Return on Equity is forecast to be low in 3 years time (9.7%).